Epilepsy in the elderly

International Journal of Gerontology

Volumn 6, Issue 2, 2012, Pages 63-67

  Chen, Lu An ^a   Cheng, Shih Jung ^a   Jou, Shuo Bin ^a  

^a MACKAY MEMORIAL HOSPITAL   (Taiwan)

Author keywords

age specific; anticonvulsants; seizure; tolerability

Indexed keywords

ALBUMIN; ANTIARRHYTHMIC AGENT; ANTICOAGULANT AGENT; ANTICONVULSIVE AGENT; ANTIHYPERTENSIVE AGENT; CARBAMAZEPINE; ETIRACETAM; GABAPENTIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LAMOTRIGINE; OXCARBAZEPINE; PHENOBARBITAL; PHENYTOIN; PSYCHOTROPIC AGENT; TOPIRAMATE; VALPROIC ACID;

ALZHEIMER DISEASE; CHRONIC KIDNEY DISEASE; CLINICAL DECISION MAKING; CLINICAL FEATURE; COMORBIDITY; DIZZINESS; DRUG ABSORPTION; DRUG CLEARANCE; DRUG EFFICACY; DRUG METABOLISM; DRUG PROTEIN BINDING; DRUG SAFETY; DRUG TOLERABILITY; EARLY DIAGNOSIS; ELECTROENCEPHALOGRAM; EPILEPSY; GAIT DISORDER; GERIATRIC PATIENT; GROUPS BY AGE; HEMODIALYSIS; HUMAN; POLYPHARMACY; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; SEDATION; SIDE EFFECT; TREATMENT RESPONSE; URINARY EXCRETION;

EID: 84862883523     PISSN: 18739598     EISSN: 1873958X     Source Type: Journal    
DOI: 10.1016/j.ijge.2012.05.013     Document Type: Review

References (71)

1. D.C. Hesdorffer, G. Logroscino, and E.K. Benn Estimating risk for developing epilepsy: a population-based study in Rochester, Minnesota Neurology 76 2011 23 27
2. W.A. Hauser Seizure disorders: the changes with age Epilepsia 33 Suppl. 4 1992 S6 14
3. W.A. Hauser, J.F. Annegers, and L.T. Kurland Incidence of epilepsy and unprovoked seizures in Rochester, Minnesota: 1935-1984 Epilepsia 34 1993 453 468
4. M.J. Pugh, D.R. Berlowitz, and L. Kazis The impact of epilepsy on older veterans Int Rev Neurobiol 81 2007 221 233
5. D.P. McLaughlin, N.A. Pachana, and K. McFarland Stigma, seizure frequency and quality of life: the impact of epilepsy in late adulthood Seizure 17 2008 281 287
6. D.P. McLaughlin, N.A. Pachana, and K. McFarland The impact of depression, seizure variables and locus of control on health related quality of life in a community dwelling sample of older adults Seizure 19 2010 232 236
7. G.K. Bergey Minimizing misdiagnoses in epilepsy in the elderly Geriatrics Suppl. 2005 May 7 12
8. L. Stephen, and M. Brodie Epilepsy in elderly people Lancet 355 2000 1441 1446
9. J.B. Godfrey Misleading presentation of epilepsy in elderly people Age Ageing 18 1989 17 20
10. N. Collins Elders with Epilepsy Med Clin North Am 90 2006 945 966
11. R.E. Ramsay, A.J. Rowan, and F.M. Pryor Special considerations in treating the elderly patient with epilepsy Neurology 62 2004 S24 S29
12. R. Alroughani, M. Javidan, and A. Qasem Non-convulsive status epilepticus; the rate of occurrence in a general hospital Seizure 18 2009 38 42
13. I. Drury, and A. Beydoun Interictal epileptiform activity in elderly patients with epilepsy Electroencephalogr Clin Neurophysiol 106 1998 369 373
14. S. Kipervasser, and M.Y. Neufeld Video-EEG monitoring of paroxysmal events in the elderly Acta Neurol Scand 116 2007 221 225
15. S. Dupont, M. Verny, and S. Harston Seizures in the elderly: Development and validation of a diagnostic algorithm Epilepsy Res 89 2010 339 348
16. G.K. Bergey Initial treatment of epilepsy: special issues in treating the elderly Neurology 63 2004 S40 S48
17. J. Cloyd, W. Hauser, and A. Towne Epidemiological and medical aspects of epilepsy in the elderly Epilepsy Res 68 Suppl. 1 2006 S39 S48
18. A.R. Towne, J.M. Pellock, and D. Ko Determinants of mortality in status epilepticus Epilepsia 35 1994 27 34
19. E.L. So, J.F. Annegers, and W.A. Hauser Population-based study of seizure disorders after cerebral infarction Neurology 46 1996 350 355
20. D.C. Hesdorffer, W.A. Hauser, and J.F. Annegers Dementia and adult-onset unprovoked seizures Neurology 46 1996 727 730
21. J.C. Amatniek, W.A. Hauser, and C. DelCastillo-Castaneda Incidence and predictors of seizures in patients with Alzheimer's disease Epilepsia 47 2006 867 872
22. W.-S. Wang, and C.-P. Liu The Clinical Presentation, Diagnosis, Treatment, and Outcome of Encephalitis: Five Years of Experience at a Medical Center in Northern Taiwan Int J Gerontol 5 2011 9 12
23. J.I. Sirven, and J. Ozuna Diagnosing epilepsy in older adults: what does it mean for the primary care physician? Geriatrics 60 2005 30 35
24. A.T. Berg, and S. Shinnar The risk of seizure recurrence following a first unprovoked seizure: a quantitative review Neurology 41 1991 965 972
25. M. Musicco, E. Beghi, and A. Solari Treatment of first tonic-clonic seizure does not improve the prognosis of epilepsy. First Seizure Trial Group (FIRST Group) Neurology 49 1997 991 998
26. D.C. Hesdorffer, E.K. Benn, and G.D. Cascino Is a first acute symptomatic seizure epilepsy? Mortality and risk for recurrent seizure Epilepsia 50 2009 1102 1108
27. L.C. Miller, and F.W. Drislane Treatment strategies after a single seizure: rationale for immediate versus deferred treatment CNS Drugs 21 2007 89 99
28. A.G. Marson When to start antiepileptic drug treatment and with what evidence? Epilepsia 49 2008 3 6
29. L.G. Kim, T.L. Johnson, and A.G. Marson Prediction of risk of seizure recurrence after a single seizure and early epilepsy: further results from the MESS trial Lancet Neurology 5 2006 317 322
30. P. Kwan, and M.J. Brodie Early identification of refractory epilepsy N Engl J Med 342 2000 314 319
31. L.J. Stephen, K. Kelly, and R. Mohanraj Pharmacological outcomes in older people with newly diagnosed epilepsy Epilepsy Behav 8 2006 434 437
32. M.J. Brodie, and L.J. Stephen Outcomes in elderly patients with newly diagnosed and treated epilepsy Int Rev Neurobiol 81 2007 253 263
33. B.E. Gidal Drug absorption in the elderly: biopharmaceutical considerations for the antiepileptic drugs Epilepsy Res 68 Suppl 1 2006 S65 S69
34. D. Battino, D. Croci, and D. Mamoli Influence of aging on serum phenytoin concentrations: a pharmacokinetic analysis based on therapeutic drug monitoring data Epilepsy Res 59 2004 155 165
35. D.J. Greenblatt Reduced serum albumin concentration in the elderly: a report from the Boston Collaborative Drug Surveillance Program J Am Geriatr Soc 27 1979 20 22
36. J.E. Ahn, J.C. Cloyd, and R.C. Brundage Phenytoin half-life and clearance during maintenance therapy in adults and elderly patients with epilepsy Neurology 71 2008 38 43
37. L.A. Bauer, and R.A. Blouin Age and phenytoin kinetics in adult epileptics Clin Pharmacol Ther 31 1982 301 304
38. L.A. Bauer, R. Davis, and A. Wilensky Valproic acid clearance: unbound fraction and diurnal variation in young and elderly adults Clin Pharmacol Ther 37 1985 697 700
39. A. Birnbaum, N.A. Hardie, and I.E. Leppik Variability of total phenytoin serum concentrations within elderly nursing home residents Neurology 60 2003 555 559
40. E. Perucca Clinical pharmacokinetics of new-generation antiepileptic drugs at the extremes of age Clin Pharmacokinet 45 2006 351 363
41. G.L. Birbeck, R.D. Hays, and X. Cui Seizure reduction and quality of life improvements in people with epilepsy Epilepsia 43 2002 535 538
42. P.A. Bill, U. Vigonius, and H. Pohlmann A double-blind controlled clinical trial of oxcarbazepine versus phenytoin in adults with previously untreated epilepsy Epilepsy Res 27 1997 195 204
43. W. Christe, G. Kramer, and U. Vigonius A double-blind controlled clinical trial: oxcarbazepine versus sodium valproate in adults with newly diagnosed epilepsy Epilepsy Res 26 1997 451 460
44. M. Dam, R. Ekberg, and Y. Loyning A double-blind study comparing oxcarbazepine and carbamazepine in patients with newly diagnosed, previously untreated epilepsy Epilepsy Res 3 1989 70 76
45. J.A. French, A.M. Kanner, and J. Bautista Efficacy and tolerability of the new antiepileptic drugs I: treatment of new onset epilepsy: report of the Therapeutics and Technology Assessment Subcommittee and Quality Standards Subcommittee of the American Academy of Neurology and the American Epilepsy Society Neurology 62 2004 1252 1260
46. The Epilepsies: The Diagnosis and Management of the Epilepsies in Adults and Children in Primary and Secondary Care 2004 National Institute for Health and Clinical Excellence London CG020
47. M.J. Pugh, J. Cramer, and J. Knoefel Potentially inappropriate antiepileptic drugs for elderly patients with epilepsy J Am Geriatr Soc 52 2004 417 422
48. M.J. Brodie, P.W. Overstall, and L. Giorgi Multicentre, double-blind, randomised comparison between lamotrigine and carbamazepine in elderly patients with newly diagnosed epilepsy. The UK Lamotrigine Elderly Study Group Epilepsy Res 37 1999 81 87
49. A.J. Rowan, R.E. Ramsay, and J.F. Collins New onset geriatric epilepsy: a randomized study of gabapentin, lamotrigine, and carbamazepine Neurology 64 2005 1868 1873
50. T. Glauser, E. Ben-Menachem, and B. Bourgeois ILAE Treatment Guidelines: evidence-based Analysis of Antiepileptic Drug Efficacy and Effectiveness as Initial Monotherapy for Epileptic Seizures and Syndromes Epilepsia 47 2006 1094 1120
51. E. Saetre, E. Perucca, and J. Isojärvi An International Multicenter Randomized Double-Blind Controlled Trial of Lamotrigine and Sustained-Release Carbamazepine in the Treatment of Newly Diagnosed Epilepsy in the Elderly Epilepsia 48 2007 1292 1302
52. R.E. Ramsay, A.J. Rowan, and J.D. Slater Effect of age on epilepsy and its treatment: results from the VA Cooperative Study [abstract] Epilepsia 35 1994 91
53. J.H. Gurwitz, T.S. Field, and L.R. Harrold Incidence and preventability of adverse drug events among older persons in the ambulatory setting J Am Med Assoc 289 2003 1107 1116
54. M.J.V. Pugh, A.C. Van Cott, and J.A. Cramer Trends in antiepileptic drug prescribing for older patients with new-onset epilepsy: 2000-2004 Neurology 70 2008 2171 2178
55. M.J.V. Pugh, P.J. Foreman, and D.R. Berlowitz Prescribing antiepileptics for the elderly - Differences between guideline recommendations and clinical practice Drugs Aging 23 2006 861 875
56. E. Kutluay, K. McCague, and J. D'Souza Safety and tolerability of oxcarbazepine in elderly patients with epilepsy Epilepsy Behav 4 2003 175 180
57. E.A. Dogan, B.E. Usta, and R. Bilgen Efficacy, tolerability, and side effects of oxcarbazepine monotherapy: a prospective study in adult and elderly patients with newly diagnosed partial epilepsy Epilepsy Behav 13 2008 156 161
58. J. Ferrendelli Use of levetiracetam in a population of patients aged 65 years and older: a subset analysis of the KEEPER trial*1 Epilepsy Behav 4 2003 702 709
59. T.M. Alsaadi, S. Koopmans, and M. Apperson Levetiracetam monotherapy for elderly patients with epilepsy Seizure 13 2004 58 60
60. V. Belcastro, C. Costa, and F. Galletti Levetiracetam in newly diagnosed late-onset post-stroke seizures: a prospective observational study Epilepsy Res 82 2008 223 226
61. V. Belcastro, C. Costa, and F. Galletti Levetiracetam monotherapy in Alzheimer patients with late-onset seizures: a prospective observational study Eur J Neurol 14 2007 1176 1178
62. J. Groselj, R. Guerrini, and J. Van Oene Experience with topiramate monotherapy in elderly patients with recent-onset epilepsy Acta Neurol Scand 112 2005 144 150
63. R.E. Ramsay, B. Uthman, and F.M. Pryor Topiramate in older patients with partial-onset seizures: A pilot double-blind, dose-comparison study Epilepsia 49 2008 1180 1185
64. A.B. Ettinger, R. Manjunath, and S.D. Candrilli Prevalence and cost of nonadherence to antiepileptic drugs in elderly patients with epilepsy Epilepsy Behav 14 2009 324 329
65. E. Faught, M.S. Duh, and J.R. Weiner Nonadherence to antiepileptic drugs and increased mortality: findings from the RANSOM Study Neurology 71 2008 1572 1578
66. M.J. Pugh, A.C. Vancott, and M.A. Steinman Choice of initial antiepileptic drug for older veterans: possible pharmacokinetic drug interactions with existing medications J Am Geriatr Soc 58 2010 465 471
67. R.A. Diaz, J. Sancho, and J. Serratosa Antiepileptic drug interactions Neurologist 14 2008 S55 S65
68. P. Ryvlin, A. Montavont, and N. Nighoghossian Optimizing therapy of seizures in stroke patients Neurology 67 2006 S3 S9
69. S. Mintzer, and R.T. Mattson Should enzyme-inducing antiepileptic drugs be considered first-line agents? Epilepsia 50 2009 42 50
70. J.G. Boggs Seizure management in the setting of hepatic disease Curr Treat Options Neurol 13 2011 333 345
71. G. Lacerda, T. Krummel, and C. Sabourdy Optimizing therapy of seizures in patients with renal or hepatic dysfunction Neurology 67 2006 S28 S33